Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention Szymon JarosławskiMondher Toumi Current Opinion 24 September 2015 Pages: 301 - 307
Pharmacovigilance Considerations for Biosimilars in the USA Gustavo GramppThomas Felix Current Opinion Open access 29 September 2015 Pages: 309 - 321
FDA Draft Guidance on the Naming of Biosimilars Sara Fernandez-Lopez Commentary 19 October 2015 Pages: 323 - 325
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast Melinda GooderhamKim Papp Review Article Open access 19 October 2015 Pages: 327 - 339
Ramucirumab: A Review in Advanced Gastric Cancer Sarah L. GreigGillian M. Keating Adis Drug Evaluation 04 September 2015 Pages: 341 - 351
Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years Matt ShirleySohita Dhillon Adis Drug Evaluation 22 September 2015 Pages: 353 - 361